Ultrasound Evaluation of Crohn's Disease

Overview

About this study

The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Crohn’s disease patients with involvement of terminal ileum (thickness > 3mm) or other segments of small or large bowel
  • Aage above 18

Exclusion Criteria:

  • Patients with change of medicine or going to surgery over the 6-months follow-up period.
  • Patients with unreliable ultrasound images due to conditions such as large body habitus or poor ultrasound imaging window.
  • Adults lacking capacity to consent.
  • Vulnerable subjects such as prisoners.
  • Pregnant women and nursing mothers.
  • Patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts.
  • Patients with history of hypersensitivity allergic reactions to ultrasound contrast agents.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20314315

Mayo Clinic Footer